57 studies found for:    Open Studies | "Breast Neoplasms, Male"
Show Display Options
Rank Status Study
21 Not yet recruiting PARP Inhibitor BMN-673 in Treating Patients With BRCA1 and BRCA2 Wild-Type, Metastatic or Recurrent, Triple-Negative or HER2-Negative Breast Cancer
Conditions: Estrogen Receptor Negative;   HER2/Neu Negative;   Male Breast Carcinoma;   Progesterone Receptor Negative;   Metastatic Breast Carcinoma;   Stage IV Breast Cancer;   Triple-Negative Breast Cancer
Interventions: Drug: PARP Inhibitor BMN-673;   Other: Laboratory Biomarker Analysis
22 Recruiting Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Metastatic Triple-Negative Breast Cancer
Conditions: Estrogen Receptor Negative;   HER2/Neu Negative;   Male Breast Carcinoma;   Progesterone Receptor Negative;   Recurrent Breast Carcinoma;   Stage IV Breast Cancer;   Triple-Negative Breast Carcinoma
Interventions: Drug: Akt Inhibitor GSK2141795;   Other: Laboratory Biomarker Analysis;   Drug: Trametinib
23 Recruiting FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer
Conditions: Estrogen Receptor Positive;   HER2/Neu Negative;   Male Breast Carcinoma;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: Fluorothymidine F-18;   Procedure: Positron Emission Tomography;   Other: Laboratory Biomarker Analysis
24 Recruiting Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer
Conditions: Male Breast Carcinoma;   Prostate Adenocarcinoma;   Recurrent Breast Carcinoma;   Recurrent Non-Small Cell Lung Carcinoma;   Recurrent Prostate Carcinoma;   Stage IV Breast Cancer;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Prostate Cancer
Intervention: Radiation: Stereotactic Radiosurgery
25 Recruiting Entinostat, Lapatinib Ditosylate and Trastuzumab in Treating Patients With Locally Recurrent or Distant Relapsed Metastatic Breast Cancer Previously Treated With Trastuzumab Only
Conditions: HER2/Neu Positive;   Invasive Breast Carcinoma;   Male Breast Carcinoma;   Recurrent Breast Carcinoma;   Stage IV Breast Cancer
Interventions: Drug: Entinostat;   Other: Laboratory Biomarker Analysis;   Drug: Lapatinib Ditosylate;   Biological: Trastuzumab
26 Recruiting Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer
Conditions: Estrogen Receptor Negative;   HER2/Neu Negative;   Male Breast Carcinoma;   Progesterone Receptor Negative;   Recurrent Breast Carcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Stage IV Breast Cancer;   Triple-Negative Breast Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Pegylated Liposomal Doxorubicin Hydrochloride;   Other: Pharmacological Study;   Drug: Veliparib
27 Recruiting Vaccine Therapy With or Without Polysaccharide-K in Treating Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy
Conditions: HER2/Neu Positive;   Male Breast Carcinoma;   Recurrent Breast Carcinoma;   Stage IV Breast Cancer
Interventions: Biological: HER-2/neu Intracellular Domain Protein;   Biological: Trastuzumab;   Biological: Pertuzumab;   Other: Placebo;   Biological: Polysaccharide-K;   Other: Laboratory Biomarker Analysis
28 Recruiting Sense of Hope Alleviates Fatigue in Breast Cancer Survivors
Condition: Carcinoma of Male Breast
Intervention:
29 Recruiting Male Breast Cancer: Understanding the Biology for Improved Patient Care
Condition: Breast Cancer
Intervention:
30 Unknown  Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
Condition: Cancer
Interventions: Drug: cyclophosphamide;   Other: laboratory biomarker analysis;   Procedure: biopsy;   Procedure: cryosurgery
31 Not yet recruiting Natural Supplements and a Special Diet in Eliminating Cancer-impacting Hormones From Sources Outside the Body in Patients With Early-Stage or Remission Prostate Cancer, Breast Cancer, or Uterine Cancer
Conditions: Breast Cancer;   Prostate Cancer;   Sarcoma
Interventions: Other: laboratory biomarker analysis;   Procedure: therapeutic dietary intervention
32 Recruiting Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery
Condition: Breast Cancer
Interventions: Biological: HER2Bi-armed activated T cells;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel;   Other: laboratory biomarker analysis;   Procedure: neoadjuvant therapy;   Procedure: therapeutic conventional surgery
33 Unknown  Radiation Therapy Followed by Surgery in Treating Patients With Early-Stage Breast Cancer
Condition: Breast Cancer
Interventions: Genetic: DNA analysis;   Genetic: RNA analysis;   Genetic: gene expression analysis;   Other: laboratory biomarker analysis;   Procedure: biopsy;   Procedure: fine-needle aspiration;   Procedure: neoadjuvant therapy;   Procedure: therapeutic conventional surgery;   Radiation: accelerated partial breast irradiation;   Radiation: image-guided radiation therapy
34 Recruiting Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer. ICORG 07-12
Conditions: Breast Cancer;   Colorectal Cancer;   Lung Cancer;   Melanoma (Skin);   Pancreatic Cancer
Intervention:
35 Unknown  Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab
Condition: Breast Cancer
Interventions: Genetic: DNA analysis;   Genetic: gene expression analysis;   Genetic: polymorphism analysis;   Genetic: protein expression analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
36 Recruiting A Breast Cancer Information Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
Conditions: Breast Cancer;   Precancerous Condition
Interventions: Other: medical chart review;   Other: questionnaire administration;   Other: study of socioeconomic and demographic variables;   Procedure: Excess human biological tissue;   Procedure: quality-of-life assessment
37 Recruiting Phase Ib Trial of Two Folate Binding Protein Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer Patients
Conditions: Breast Cancer;   Ovarian Cancer
Interventions: Biological: E39 peptide vaccine;   Biological: E39 vaccine then J65 vaccine;   Biological: J65 vaccine then E39 vaccine
38 Recruiting Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
Conditions: Breast Cancer;   Cardiac Toxicity
Interventions: Drug: Coreg CR®;   Drug: lisinopril;   Other: placebo
39 Unknown  Docetaxel With or Without a Phytochemical in Treating Patients With Breast Cancer
Condition: Breast Cancer
Interventions: Dietary Supplement: phytochemical;   Drug: docetaxel;   Procedure: complementary or alternative medicine procedure
40 Unknown  Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer
Conditions: Breast Cancer;   Cervical Cancer;   Endometrial Cancer;   Ovarian Cancer
Interventions: Drug: fluorouracil;   Drug: pegylated liposomal doxorubicin hydrochloride;   Procedure: hyperthermia treatment

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-57) Show next page of results    Last Page
Indicates status has not been verified in more than two years